(Total Views: 359)
Posted On: 05/14/2021 2:34:42 AM
Post# of 22465
I look at it that Innova has made $4.4 Billion in sales in just the UK and for some reason thinks enough of QMCs prospects to invest in and own the company. Pasaca sees QMCs blockchain, QD and anticounterfeiting, and other potential industries and wants to participate in it's development.
What's interesting is that Innova bought some production and clinical labs and hired Dr Malan and are pursuing those testing related markets. QMC's use to Innova is the interconnectivity it brings which can increase sales of testing products within the ecosystem. The more connections, the more testing sales, but they are separate businesses. In fact, I don't see much synchrony between Pasaca's other portfolio companies and QMC, but Innova and QMC are two pieces that work together well.
We're hooked up for startup funding of expansion and new products with Pasaca, and we're partners with Innova who's done near $4.5B in sales over just half a year, Oct to March. What's your question about survivability, again?
What's interesting is that Innova bought some production and clinical labs and hired Dr Malan and are pursuing those testing related markets. QMC's use to Innova is the interconnectivity it brings which can increase sales of testing products within the ecosystem. The more connections, the more testing sales, but they are separate businesses. In fact, I don't see much synchrony between Pasaca's other portfolio companies and QMC, but Innova and QMC are two pieces that work together well.
We're hooked up for startup funding of expansion and new products with Pasaca, and we're partners with Innova who's done near $4.5B in sales over just half a year, Oct to March. What's your question about survivability, again?
(0)
(0)
